Frazier Life Sciences IX, L.P. is a venture capital fund based in Seattle, Washington. According to its most recent Form D, filed Nov 1, 2017, it has sold $418,925,000 of interests to 55 investors since its first sale in Oct 2017. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Fhmls IX, L.l.c; Daniel Estes; Fhmls IX, L.p.
- Total raised
- $418,925,000Cumulative sales reported on Form D
- Investors
- 55
- First sale
- Oct 31, 2017
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Fhmls IX, L.l.c; Daniel Estes; Fhmls IX, L.p
- Latest Form D
- Nov 1, 2017
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about Frazier Life Sciences IX, L.P.
What is the minimum investment for Frazier Life Sciences IX, L.P.?
Frazier Life Sciences IX, L.P.'s latest Form D, filed Nov 1, 2017, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in Frazier Life Sciences IX, L.P.?
Frazier Life Sciences IX, L.P. is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has Frazier Life Sciences IX, L.P. raised?
Frazier Life Sciences IX, L.P. reports $418,925,000 sold from 55 investors on its Form D filed Nov 1, 2017. This is cumulative sales since the offering began, not current assets or performance.
Where is Frazier Life Sciences IX, L.P. based?
Frazier Life Sciences IX, L.P. is based in Seattle, Washington.
When did Frazier Life Sciences IX, L.P. launch?
Frazier Life Sciences IX, L.P. reports its first sale in Oct 2017.
Size compared with every venture capital fund
Raised more than 100% of the 5,403 venture capital funds based in Washington, and more than 100% of all 14,800 that report sales.